Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;7(6):1480-91.
doi: 10.1038/mi.2014.36. Epub 2014 May 21.

Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis

Affiliations

Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis

D Demon et al. Mucosal Immunol. 2014 Nov.

Erratum in

  • Mucosal Immunol. 2014 Nov;7(6):1504

Abstract

Ulcerative colitis and Crohn's disease are major inflammatory syndromes that affect millions of patients. Caspase-11 confers protection against Gram-negative enteropathogens, but its role during colitis is unknown. Here, we show that caspase-11 was constitutively expressed in the colon, and that caspase-11-deficient (caspase-11(-/-)) mice were hypersusceptible to dextran sodium sulfate (DSS)-induced colitis. Notably, pro-inflammatory Prevotella species were strongly reduced in the gut microbiota of caspase-11(-/-) mice. Co-housing with wild-type mice leveled Prevotella contents, but failed to protect caspase-11(-/-) mice from increased susceptibility to DSS-induced colitis. We therefore addressed the role of caspase-11 in immune signaling. DSS-induced tissue damage and inflammatory cell infiltration in the gut were markedly increased in caspase-11−/− mice, while release of the pyroptosis/necroptosis marker HMGB1 was abolished [Corrected]. Moreover, caspase-11(-/-) mice showed normal or increased production of mature interleukin (IL)-1β and IL-18, whereas IL-1β and IL-18 secretion was blunted in animals lacking both caspases 1 and 11. In conclusion, we showed that caspase-11 shapes the gut microbiota composition, and that caspase-11(-/-) mice are highly susceptible to DSS-induced colitis. Moreover, DSS-induced inflammasome activation relied on caspase-1, but not caspase-11. These results suggest a role for other caspase-11 effector mechanisms such as pyroptosis in protection against intestinal inflammation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1. Caspase-11 deficiency sensitizes mice to DSS-induced morbidity and lethality
(a) Schematic of the design of the survival study and the studies for the collection of serum and colon samples. In general, mice were fed a 2% or 4% DSS solution in drinking water for 5 days, followed by normal drinking water until the end of the experiment. (b) Kaplan-Meier survival plot of C57BL/6J, caspase-11-/- (C11-/-) and caspase-1-/-/11-/- (C1-/-/11-/-) mice induced with 4% DSS (n=10/group). (c-d) The percentage of body weight (c) and the clinical score (d) of C57BL/6J, C11-/- and C1-/-/11-/- mice induced with 2% DSS. Data depict the mean ± SEM (n=10/group). Statistical significance between DSS-treated C57BL/6J and Casp11-/- mice is indicated. (e) Macroscopic pictures and (f) graphic presentation of the colon length of C57BL/6J, C11-/- and C1-/-/11-/- mice without (0% DSS) or 10 days after induction with 2% DSS. Data in panel f depict individual replicates with mean; C57BL/6J mice (0% DSS, n=8; 2%, n=7), Casp11-/- mice (0% DSS, n=6; 2%, n=11) and Casp1-/-/Casp11-/- mice (0% DSS, n=4; 2% DSS, n=6). Statistical significance between DSS-treated C57BL/6J, C11-/- and C1-/-/11-/- mice is indicated. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Figure 2
Figure 2. The microbiome of caspase-11-/- mice contains reduced Prevotellacea, but this is not associated with their hypersensitivity towards DSS-induced colitis
(a-b) Expression of the microbial phyla Prevotellacea (a) and Bacteroides (b) in the fecal samples of separately housed C57BL/6J and caspase-11-/- (C11-/-) mice before (day 0) and 10 days after the start of 2% DSS administration. Data depict the mean ± SD (n=6/group). (c-d) Expression of the microbial species Prevotellaceae (c) and Bacteroides (d) in the fecal samples of C57BL/6J and C11-/- mice that were first co-housed together for 4 weeks (day 0) and then induced with 2% DSS (day 10). Data depict the mean ± SD (n = 12/group). (e-h) The percentage of body weight (e), the clinical score (f), and macroscopic pictures and (h) graphic presentation of the colon length of C57BL/6J and C11-/- mice that were co-housed together for 4 weeks and afterwards induced with 2% DSS. Data depict the mean ± SEM (e-f; n=12/group) or individual replicates with mean (h; n=12/group). Statistical significance between DSS-treated C57BL/6J and C11-/- mice is indicated. *, P < 0.05; **, P < 0.01; ***, P < 0.001, n.s., not significant.
Figure 3
Figure 3. Caspase-11-/- mice show increased colonic tissue damage and leukocyte infiltration, despite normal apoptosis
(a-b) Representative microscopic pictures (a) and semi-quantitative scoring (b) of hematoxylin and eosin (H&E)-stained colon sections of DSS-treated C57BL/6J, caspase-11-/- (C11-/-) and Caspase-1-/-/11-/- (C1-/-/11-/-) mice without (0% DSS) or 10 days after induction with 2% DSS. (c-d) Representative microscopic pictures (c) and semi-quantitative scoring (d) of hematoxylin and eosin (H&E)-stained colon sections of DSS-treated C57BL/6J and C11-/- mice that were co-housed together for 4 weeks and afterwards induced with 2% DSS. Data depict the mean ± SD (b; n=4/group and d; n=5/group). Bars: 100 μm. (e-f) Representative microscopic pictures (e) and quantification of the number of TUNEL-positive cells per field (f) of DSS-treated C57BL/6J, C11-/- and C1-/-/11-/- mice 3 days after induction with 4% DSS. Bars: 50 μm. Data depict the mean ± SEM in 5 (0% DSS) and 10 (4% DSS) optical fields per mouse, respectively (n=4/group). Statistical significance between DSS-treated C57BL/6J, C11-/- and C1-/-/11-/- mice is indicated. n.s., not significant.
Figure 4
Figure 4. Increased colonic expression of CCL5 correlates with higher inflammatory cell infiltration in caspase-11-/- mice after DSS treatment
(a-c) Production of IL-6 (a), KC (b) and CCL5 (c) in the colon of C57BL/6J, caspase-11-/- (C11-/-) and caspase-1-/-/11-/- (C1-/-/11-/-) mice without (0% DSS) or 10 days after induction with 2% DSS. (d-f) Production of IL-6 (d), KC (e) and CCL5 (f) in the colon of C57BL/6J and C11-/- mice without (0% DSS) or 7 days after induction with 4% DSS. Data depict the individual replicates with mean; C57BL/6J mice (0% DSS, n=8; 2%, n=7 and 4%, n=10), C11-/- mice (0% DSS, n=6; 2%, n=11 and 4%, n=10) and C1-/-/11-/- mice (0% DSS, n=4 and 2%, n=6). Statistical significance between DSS-treated C57BL/6J, C11-/- and C1-/-/11-/- mice is indicated. *, P < 0.05; **, P < 0.01, ***, P < 0.001; n.s., not significant. (g-h) Photomicrographs of macrophage (F4/80) and neutrophil (Ly6G) staining on representative colon sections of DSS-treated C57BL/6J and C11-/- mice without (0% DSS; n=4/group) or 10 days after induction with 2% DSS (n=4/group). Bars: 100 μm.
Figure 5
Figure 5. Systemic cytokine and chemokine production is unaltered in DSS-treated caspase-11-/- mice
(a-c) Release of TNF (a), KC (b) and eotaxin (c) in the serum of C57BL/6J, caspase-11-/- (C11-/-) and caspase-1-/-/11-/- (C1-/-/11-/-) mice without (0% DSS) or 10 days after induction with 2% DSS. (d-f) Release of TNF (d), KC (e) and eotaxin (f) in the serum of C57BL/6J and C11-/- mice 7 days after induction with 4% DSS. Data are presented as individual replicates with mean; C57BL/6J mice (0% DSS, n=8; 2%, n=7 and 4%, n=10), C11-/- mice (0% DSS, n=6; 2%, n=11 and 4%, n=10) and C1-/-/11-/- mice (0% DSS, n=4 and 2%, n=6). Statistical significance between DSS-treated C57BL/6J, C11-/- and C1-/-/11-/- mice is indicated. n.s., not significant. (g) Representative serum samples of C57BL/6J, C11-/- and C1-/-/11-/- mice without (0% DSS), 10 days after induction with 2% DSS or 7 days after induction with 4% DSS were analyzed by Western blotting for HMGB1 release. Ponceau staining was used as loading control.
Figure 6
Figure 6. Increased secretion of IL-18 in colons of DSS-treated caspase-11-/- mice
(a, c) Production of IL-1β and IL-18 in the colon of C57BL/6J, caspase-11-/- (C11-/-) and caspase-1-/-/11-/- (C1-/-/11-/-) mice without (0% DSS) or 10 days after induction with 2% DSS. (b, d) Production of IL-1β and IL-18 in the colon of C57BL/6J and C11-/- mice 7 days after induction with 4% DSS. Data are presented as individual replicates with mean; C57BL/6J mice (0% DSS, n=8; 2%, n=7 and 4%, n=10), C11-/- mice (0% DSS, n=6; 2%, n=11 and 4%, n=10) and C1-/-/11-/- mice (0% DSS, n=4 and 2%, n=6). Statistical significance between DSS-treated C57BL/6J, C11-/- and C1-/-/11-/- mice is indicated. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (e) Protein extracts of representative colon samples from (a) and (b) were analyzed by Western blotting for IL-18 maturation and caspase-11 induction. (f) Colonic epithelial cells from 2% DSS-fed C57BL/6J, C11-/- and C1-/-/11-/- mice (pool of n=5/group) were isolated and enriched by FACS-assisted sorting as described in the Methods section. Protein extracts of colonic epithelial cells before (unsorted) and after sorting were analyzed by Western blotting for caspase-1 processing and caspase-11 induction. β-actin was used as loading control in (e) and (f).

References

    1. Jostins L, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24. - PMC - PubMed
    1. Kitajima S, Takuma S, Morimoto M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim. 1999;48:137–43. - PubMed
    1. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology. 1994;107:1643–52. - PubMed
    1. Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012;28:137–61. - PubMed
    1. Villani AC, et al. Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility. Nat Genet. 2009;41:71–6. - PMC - PubMed

Publication types

MeSH terms